TABLE 2.
Univariable analysis |
Multivariable analysis |
||||
Crude OR (95% CI) | P-value | Adjusted OR (95% CI) | P-value | P-value after Bonferroni correction | |
Changes in cognitive symptoms | |||||
Age | 1.00 (0.99 – 1.00) | 0.24 | |||
Sex (men vs. women) | 1.15 (1.01 – 1.30) | 0.03 | 1.13 (0.99 – 1.29) | 0.07 | 1 |
Duration of the disease (years) | 0.95 (0.93 – 0.97) | <0.001 | 0.94 (0.92 – 0.97) | <0.001 | <0.001 |
Duration of quarantine (days) | 1.00 (0.99 – 1.01) | 0.97 | |||
Disease severity – CDR 2 | 1.29 (1.11 – 1.50) | <0.001 | 1.19 (1.00 – 1.42) | 0.05 | 1 |
Disease severity – CDR 3 | 1.02 (0.86 – 1.21) | 0.81 | 0.93 (0.74 – 1.17) | 0.52 | 1 |
Total physical independence | 1.74 (1.40 – 2.16) | <0.001 | 1.85 (1.42 – 2.39) | <0.001 | <0.001 |
Partial physical independence | 2.19 (1.80 – 2.67) | <0.001 | 2.08 (1.68 – 2.57) | <0.001 | <0.001 |
Total awareness of pandemic | 0.74 (0.65 – 0.85) | <0.001 | 0.68 (0.57 – 0.81) | <0.001 | <0.001 |
Partial awareness of pandemic | 1.39 (1.18 – 1.64) | <0.001 | 1.20 (1.00 – 1.43) | 0.05 | 1 |
Changes in motor symptoms | |||||
Age | 1.03 (1.02 – 1.04) | <0.001 | 1.02 (1.01 – 1.03) | <0.001 | 0.001 |
Sex (men vs. women) | 1.11 (0.98 – 1.25) | 0.12 | |||
Duration of the disease (years) | 1.05 (1.03 – 1.07) | <0.001 | 1.00 (0.98 – 1.03) | 0.86 | 1 |
Duration of quarantine (days) | 1.00 (0.99 – 1.01) | 0.99 | |||
Disease severity – CDR 2 | 1.94 (1.65 – 2.29) | <0.001 | 1.29 (1.07 – 1.56) | 0.009 | 0.29 |
Disease severity – CDR 3 | 3.08 (2.56 – 3.70) | <0.001 | 1.60 (1.26 – 2.02) | <0.001 | 0.004 |
Total physical independence | 0.32 (0.25 – 0.40) | <0.001 | 0.49 (0.37 – 0.64) | <0.001 | <0.001 |
Partial physical independence | 0.93 (0.77 – 1.12) | 0.44 | 1.06 (0.86 – 1.30) | 0.59 | 1 |
Total awareness of pandemic | 0.44 (0.38 – 0.51) | <0.001 | 0.76 (0.64 – 0.91) | 0.003 | 0.10 |
Partial awareness of pandemic | 0.75 (0.64 – 0.88) | <0.001 | 0.93 (0.78 – 1.10) | 0.39 | 1 |
OR, Odds ratio; 95% CI, 95% confidence interval; CDR, Clinical Dementia Rating.